ConductScience.org, home

Paper3277680

Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.

Hehlmann R and 9 others. Blut, 1988. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha. Papers, record 3277680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3277680

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.
PubMed
Journal
Blut
PubMed
Year
1988
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2019-09-03
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hehlmann RR
2Anger BB
3Messerer DD
4Zankovich RR
5Bergmann LL
6Kolb HJH J
7Meyer PP
8Essers UU
9Queisser UU
10Vaupel HH

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BusulfanMajor topic
HydroxyureaMajor topic
Interferon Type IMajor topic
Leukemia, MyeloidMajor topic
Clinical Trials as Topic
Humans
Middle Aged
Random Allocation

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14552811Hydroxyurea therapy in chronic myelogenous leukemia.Cancer1972https://conductscience.org/library/papers/4552811PubMed
26956430Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia.Cancer1982https://conductscience.org/library/papers/6956430PubMed
3282922Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol).Blood1979https://conductscience.org/library/papers/282922PubMed
43457264Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.N Engl J Med1986https://conductscience.org/library/papers/3457264PubMed
513712355Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy.Blood1961https://conductscience.org/library/papers/13712355PubMed
67012623Chronic myelogenous leukemia--new concepts (first of two parts).N Engl J Med1981https://conductscience.org/library/papers/7012623PubMed
76584184Prognostic discrimination in "good-risk" chronic granulocytic leukemia.Blood1984https://conductscience.org/library/papers/6584184PubMed
887832Karyotypic conversion in Ph1-positive chronic myeloid leukaemia with combination chemotherapy.Lancet1979https://conductscience.org/library/papers/87832PubMed
93516621[alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia].Dtsch Med Wochenschr1986https://conductscience.org/library/papers/3516621PubMed
103526559Management of chronic myelogenous leukemia.Semin Hematol1986https://conductscience.org/library/papers/3526559PubMed
113864497Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.Blood1985https://conductscience.org/library/papers/3864497PubMed
123463397Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia.Cancer1986https://conductscience.org/library/papers/3463397PubMed
133510388Bone marrow transplantation for patients with chronic myeloid leukemia.N Engl J Med1986https://conductscience.org/library/papers/3510388PubMed
143855444Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia.J Clin Oncol1985https://conductscience.org/library/papers/3855444PubMed
153113712A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B.Cancer1987https://conductscience.org/library/papers/3113712PubMed
163511810Marrow transplantation for the treatment of chronic myelogenous leukemia.Ann Intern Med1986https://conductscience.org/library/papers/3511810PubMed
173904870Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation.Blood1985https://conductscience.org/library/papers/3904870PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
2796252Budd-Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases.Klin Wochenschr1989https://conductscience.org/library/papers/2796252PubMed
2736308A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.Blut1989https://conductscience.org/library/papers/2736308PubMed
2644994Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a.Blut1989https://conductscience.org/library/papers/2644994PubMed
2597774Polycythemia vera. A clinical study of 141 patients.Blut1989https://conductscience.org/library/papers/2597774PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3277680

GET https://conductscience.org/api/papers/v1/3277680/authors